Concepedia

Author

Christine Voors‐Pette

QPS (Netherlands)

Also Known As

C. Voors-Pette, Christine Voors-Pette, Christine Voors‐Pette

22

Publications

344

Citations

9

H-Index

16

Concepts

All Affiliations

QPS (Netherlands)Maastricht University Medical CentreInstitut Galien Paris-SaclayInsermParis Biotech Santé
CV

About

Christine Voors‐Pette is an author at QPS (Netherlands) specializing in obesity, metabolic syndrome, and atherosclerosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

99

2

Health Sciences

1

1

29

3

Public Health

1

1

70

4

Diabetes

1

1

29

5

Epidemiology

1

1

70

Christine Voors‐Pette

×

8

Publications

308

Citations

8

H-Index

YearCitations

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom,

Arteriosclerosis Thrombosis and Vascular Biology

2019

111

Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity

Christine Voors‐Pette, Tjerk W.A. de Bruin

Atherosclerosis

2001

70

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation

Lionel Renaud, Kristell Lebozec, Christine Voors‐Pette,

The Journal of Clinical Pharmacology

2020

33

Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus

Carla Kallen, Christine Voors‐Pette, Freek G. Bouwman,

Atherosclerosis

2002

29

Abdominal Obesity and Expression of Familial Combined Hyperlipidemia

Carla Kallen, Christine Voors‐Pette, Tjerk W.A. de Bruin

Obesity Research

2004

26

Effect of Rifampin‐Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel

Uta Schilling, Jasper Dingemanse, Christine Voors‐Pette,

Clinical and Translational Science

2020

14

Pharmacokinetics, pharmacodynamics and safety of the novel C‐X‐C chemokine receptor 3 antagonist ACT‐777991: Results from the first‐in‐human study in healthy adults

Marie‐Laure Boof, Martine Géhin, Christine Voors‐Pette,

British Journal of Clinical Pharmacology

2023

14

Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals

Ali Abbara, Mike Ufer, Christine Voors‐Pette,

Fertility and Sterility

2023

11

Page 1